Pressure BioSciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pressure BioSciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14% to $1,977,763. Profit margin reached -1482%. Total operating expenses were $10,302,920.

Profit Margin

Pressure BioSciences, Inc. (OTC:PBIO): Profit margin
2014 1.37M -4.61M -335.52%
2015 1.79M -7.41M -412.49%
2016 1.97M -2.70M -136.96%
2017 2.24M -10.71M -478.27%
2018 2.45M -9.69M -394.62%
2019 1.80M -11.66M -644.25%
2020 1.22M -24.34M -1994.92%
2021 2.00M -34.60M -1728.14%
2022 1.72M -16.82M -972.88%
2023 1.97M -29.31M -1482.19%

PBIO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
1.97M1.72M2.00M1.22M1.80M2.45M2.24M1.97M1.79M1.37M
Cost of revenue
1.17M2.01M942.38K582.85K1.19M1.28M1.27M834.01K609.05K652.43K
Gross profit
799.56K-284.66K1.05M637.73K612.93K1.17M967.14K1.14M1.18M722.30K
Operating exp.
Research and development
1.36M969.53K1.10M1.14M1.15M1.20M988.59K1.18M1.10M952.55K
Selling and marketing
730.71K401.44K324.72K649.78K680.62K1.00M1.20M872.36K745.57K721.22K
Total operating expenses
10.30M4.61M5.24M5.22M6.41M5.65M5.61M4.87M4.75M4.06M
Operating income
-9.50M-4.89M-4.18M-4.58M-5.80M-4.47M-4.64M-3.73M-3.56M-3.33M
Other income (expenses), net
-19.81M-11.17M-15.96M-11.41M-6.07M-1.05M-6.06M5.52M-3.85M-1.27M
Income before tax
-29.31M-16.07M-20.15M-16.00M-11.87M-9.69M-10.71M-2.70M-7.41M-4.61M
Income tax expense
0747.67K14.45M8.34M-217.16K-1.05M5.86M4.50M4.14M1.30M
Net income
-29.31M-16.82M-34.60M-24.34M-11.66M-9.69M-10.71M-2.70M-7.41M-4.61M
Earnings per share
Basic EPS
-1.51-1.52-5.21-7.37-5.87-6.34-9.62-2.97-10.73-9.7
Diluted EPS
-1.51-1.52-5.21-7.37-5.87-6.34-9.62-2.97-10.73-9.7
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source